Chemotherapy-Induced Nausea

Olanzapine reduced severe nausea more effectively than prochlorperazine for patients with refractory symptoms after chemotherapy, according to results of a randomized phase 3 trial.

SAN ANTONIO — Low-dose olanzapine appeared noninferior to the standard dose for controlling chemotherapy-induced nausea and vomiting without requiring delayed steroids among patients with solid tumors, according to study results.

Chemotherapy-induced nausea remains a significant clinical problem, but severity varies based on multiple factors, according to results presented during the virtual Oncology Nursing Society Congress.